" /> Nevus, epidermal - CISMeF





Preferred Label : Nevus, epidermal;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Nevus, keratinocytic, nonepidermolytic;

Included titles and symbols : Nevus sebaceous; Nevus, woolly hair;

Description : Epidermal nevi are congenital lesions that affect about 1 in 1,000 people. They appear at or shortly after birth as localized epidermal thickening with hyperpigmentation that frequently follow the lines of Blaschko, suggesting that they result from postzygotic somatic mutation in the skin (Paller et al., 1994). A rare subgroup of epidermal nevi is clinically indistinguishable from other epidermal nevi, but displays histopathologic features typical of epidermolytic hyperkeratosis (see EHK, 113800), and patients with this type of epidermal nevi sometimes have offspring with generalized EHK (Paller et al., 1994). See giant pigmented hairy nevus (137550) and malignant melanoma (155600). Nevus sebaceous is a benign congenital skin lesion that preferentially affects the scalp and face. It occurs in about 1 in 1,000 live births and is characterized by hairless, yellow-orange plaques of various size and shape. Histology shows that nevus sebaceous is a hamartoma consisting of epidermal, sebaceous, and apocrine elements. About 24% of nevi develop secondary tumors, some of which may be malignant (summary by Groesser et al., 2012).;

Inheritance : Somatic mutation;

Molecular basis : Caused by somatic mutation in the fibroblast growth factor receptor-3 gene (FGFR3, 134934.0001); Caused by somatic mutation in the HRas proto-oncogene, GTPase gene (HRAS, 190020.0001); Caused by somatic mutation in the phosphatidylinositol 3-kinase, catalytic, alpha polypeptide gene (PIK3CA, 171834.0004); Caused by somatic mutation in the NRAS proto-oncogene, GTPase gene (NRAS, 164790.0002);

Prefixed ID : #162900;

Details


You can consult :


Nous contacter.
29/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.